secwatch.observer — SEC 8-K summary
======================================

Issuer:     RANGE IMPACT, INC. (RNGE)
CIK:        0001438943
Form:       8-K
Filed at:   2024-10-02T23:59:59+00:00
Accession:  0001493152-24-039195
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Range Impact sells cannabinoid drug unit Graphium for warrants and cash
-----------------------------------------------------------------------

- Sold all Graphium common stock to Placer Biosciences, owned by former officers Dr. Zipp and Mr. McKilligan.
- Consideration: warrants for 25% of Placer common stock (exercise price $0.01, expiring 2034), de minimis cash, 50% of equipment sale proceeds over 12 months.
- Graphium held IP, permits, and lab equipment for early-stage cannabinoid therapeutics targeting Crohn’s disease and colitis.
- Divestiture part of strategic shift to focus on acquiring, reclaiming, and repurposing mine land in Appalachia.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1438943/000149315224039195/0001493152-24-039195-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1438943/000149315224039195/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-039195

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer